143 related articles for article (PubMed ID: 35504431)
1. Sphingomyelin-based PEGylation Cu (DDC)
Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
4. Activate the endogenous Cu
Liang X; Li C; Yuan W; Ji M; Zhang J; Yan M; Lu Q; Gou J; Yin T; He H; Tang X; Zhang Y
Int J Pharm; 2024 Mar; 652():123800. PubMed ID: 38218507
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
Talanta; 2020 May; 211():120732. PubMed ID: 32070566
[TBL] [Abstract][Full Text] [Related]
7. The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)
Liu H; Kong Y; Liang X; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Expert Opin Drug Deliv; 2023 Jan; 20(1):145-158. PubMed ID: 36462209
[TBL] [Abstract][Full Text] [Related]
8. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
[TBL] [Abstract][Full Text] [Related]
9. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
McMahon A; Chen W; Li F
J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
[TBL] [Abstract][Full Text] [Related]
10. Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)
Hartwig F; Köll-Weber M; Süss R
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204205
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
12. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment.
Xu L; Sun Y; Li Y; Sun J; Guo Y; Shen Q; Wei Q; Shen JW
Int J Pharm; 2022 Oct; 626():122130. PubMed ID: 36007849
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy.
Peng Y; Liu P; Meng Y; Hu S; Ding J; Zhou W
Mol Pharm; 2020 Aug; 17(8):2864-2873. PubMed ID: 32551674
[TBL] [Abstract][Full Text] [Related]
16. Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.
Wehbe M; Anantha M; Backstrom I; Leung A; Chen K; Malhotra A; Edwards K; Bally MB
PLoS One; 2016; 11(4):e0153416. PubMed ID: 27055237
[TBL] [Abstract][Full Text] [Related]
17. Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
Kang X; Wang J; Huang CH; Wibowo FS; Amin R; Chen P; Li F
Nanomedicine; 2023 Jan; 47():102620. PubMed ID: 36265559
[TBL] [Abstract][Full Text] [Related]
18. Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.
Zhou L; Yang L; Yang C; Liu Y; Chen Q; Pan W; Cai Q; Luo L; Liu L; Jiang S; He H; Zhang Y; Yin T; Tang X
Pharm Res; 2018 May; 35(7):147. PubMed ID: 29796711
[TBL] [Abstract][Full Text] [Related]
19. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
[TBL] [Abstract][Full Text] [Related]
20. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]